Skip to main content

Systemic bevacizumab leads to resolution of diabetic macular edema.

Publication ,  Journal Article
Ehlers, JP; Fekrat, S
Published in: Retin Cases Brief Rep
2010

PURPOSE: The purpose of this study is to report a case of diabetic macular edema that resolved after systemic bevacizumab. METHODS: This is an observational case report of a patient with diabetic macular edema. RESULTS: After initiation of systemic bevacizumab for a central nervous system glioblastoma, the diabetic macular edema resolved. CONCLUSION: Systemic bevacizumab may result in the resolution of macular edema secondary to diabetes.

Duke Scholars

Published In

Retin Cases Brief Rep

DOI

ISSN

1935-1089

Publication Date

2010

Volume

4

Issue

4

Start / End Page

297 / 299

Location

United States

Related Subject Headings

  • 3212 Ophthalmology and optometry
  • 1113 Opthalmology and Optometry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ehlers, J. P., & Fekrat, S. (2010). Systemic bevacizumab leads to resolution of diabetic macular edema. Retin Cases Brief Rep, 4(4), 297–299. https://doi.org/10.1097/ICB.0b013e3181b86238
Ehlers, Justis P., and Sharon Fekrat. “Systemic bevacizumab leads to resolution of diabetic macular edema.Retin Cases Brief Rep 4, no. 4 (2010): 297–99. https://doi.org/10.1097/ICB.0b013e3181b86238.
Ehlers JP, Fekrat S. Systemic bevacizumab leads to resolution of diabetic macular edema. Retin Cases Brief Rep. 2010;4(4):297–9.
Ehlers, Justis P., and Sharon Fekrat. “Systemic bevacizumab leads to resolution of diabetic macular edema.Retin Cases Brief Rep, vol. 4, no. 4, 2010, pp. 297–99. Pubmed, doi:10.1097/ICB.0b013e3181b86238.
Ehlers JP, Fekrat S. Systemic bevacizumab leads to resolution of diabetic macular edema. Retin Cases Brief Rep. 2010;4(4):297–299.

Published In

Retin Cases Brief Rep

DOI

ISSN

1935-1089

Publication Date

2010

Volume

4

Issue

4

Start / End Page

297 / 299

Location

United States

Related Subject Headings

  • 3212 Ophthalmology and optometry
  • 1113 Opthalmology and Optometry